Recent studies have shown that TIP5 exerts oncogenic effects in Hepatocellular Carcinoma (HCC) by activating β-catenin/TCF7L2 signaling, suggesting that TIP5 may be a promising therapeutic target for HCC.15 This evidence concerns the gene TCF7L2 and hepatocellular carcinoma.